TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Elizabeth S Duke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.